Sebela Ireland Ltd Company Profile

✉ Email this page to a colleague

SEBELA IRELAND LTD has seventeen approved drugs.

There are eleven US patents protecting SEBELA IRELAND LTD drugs.

There are eighty-three patent family members on SEBELA IRELAND LTD drugs in thirty-six countries and two supplementary protection certificates in two countries.

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sebela Ireland Ltd	NAFTIN	naftifine hydrochloride	GEL;TOPICAL	204286-001	Jun 27, 2013	AB	RX	Yes	Yes	8,778,365	⤷ Subscribe	Y			⤷ Subscribe
Sebela Ireland Ltd	NAFTIN	naftifine hydrochloride	GEL;TOPICAL	204286-001	Jun 27, 2013	AB	RX	Yes	Yes	10,729,667	⤷ Subscribe	Y			⤷ Subscribe
Sebela Ireland Ltd	BRISDELLE	paroxetine mesylate	CAPSULE;ORAL	204516-001	Jun 28, 2013	AB	RX	Yes	Yes	7,598,271	⤷ Subscribe		Y		⤷ Subscribe
Sebela Ireland Ltd	PRAMOSONE	hydrocortisone acetate; pramoxine hydrochloride	LOTION;TOPICAL	085979-001	Approved Prior to Jan 1, 1982		RX	No	No		⤷ Subscribe				⤷ Subscribe
Sebela Ireland Ltd	NAFTIN	naftifine hydrochloride	GEL;TOPICAL	204286-001	Jun 27, 2013	AB	RX	Yes	Yes	9,161,914	⤷ Subscribe				⤷ Subscribe
Sebela Ireland Ltd	MOTOFEN	atropine sulfate; difenoxin hydrochloride	TABLET;ORAL	017744-002	Approved Prior to Jan 1, 1982		RX	Yes	Yes		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Sebela Ireland Ltd	PEXEVA	paroxetine mesylate	TABLET;ORAL	021299-001	Jul 3, 2003	5,874,447	⤷ Subscribe
Sebela Ireland Ltd	NAFTIN	naftifine hydrochloride	CREAM;TOPICAL	019599-001	Feb 29, 1988	4,282,251	⤷ Subscribe
Sebela Ireland Ltd	LOTRONEX	alosetron hydrochloride	TABLET;ORAL	021107-001	Feb 9, 2000	5,360,800	⤷ Subscribe
Sebela Ireland Ltd	ONMEL	itraconazole	TABLET;ORAL	022484-001	Apr 29, 2010	7,081,255	⤷ Subscribe
Sebela Ireland Ltd	PEXEVA	paroxetine mesylate	TABLET;ORAL	021299-001	Jul 3, 2003	6,703,408	⤷ Subscribe
Sebela Ireland Ltd	TRANDATE	labetalol hydrochloride	INJECTABLE;INJECTION	019425-001	Dec 31, 1985	4,066,755	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Capsules	7.5 mg	➤ Subscribe	2014-04-07
➤ Subscribe	Tablets	0.5 mg and 1 mg	➤ Subscribe	2010-12-02

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration
Ukraine	96770	⤷ Subscribe
Japan	5895009	⤷ Subscribe
Japan	2009504589	⤷ Subscribe
World Intellectual Property Organization (WIPO)	9856787	⤷ Subscribe
Japan	2014077023	⤷ Subscribe
Norway	20090639	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Subscribe
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0809498	10C0038	France	⤷ Subscribe	PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
0809498	SPC/GB10/012	United Kingdom	⤷ Subscribe	PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.